The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Human Formyl Peptide Receptor 2 Senses Highly Pathogenic Staphylococcus aureus
Open accessAbstract
SUMMARY Virulence of the emerging Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA) and other highly pathogenic S. aureus depends on the recently discovered phenol-soluble modulin (PSM) peptide toxins, which combine the capacities to attract and lyse neutrophils. The molecular basis of PSM-stimulated neutrophil recruitment has remained unknown. We demonstrate that the human formyl peptide receptor 2 (FPR2/ALX), which has previously been implicated in control of endogenous inflammatory processes, senses PSMs at nanomolar concentrations and initiates proinflammatory neutrophil responses to CA-MRSA. Specific blocking of FPR2/ALX or deletion of PSM genes in CA-MRSA led to severely diminished capacities of neutrophils to detect CA-MRSA. A specific inhibitor of FPR2/ALX and its functional mouse counterpart blocked PSM-mediated leukocyte infiltration in vivo in a mouse model. Thus, the innate immune system uses a new FPR2/ALX-dependent mechanism to sense bacterial peptide toxins and detect highly virulent bacterial pathogens. FPR2/ALX represents an attractive target for new anti-infective or anti-inflammatory strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Wang, R., Braughton, K. R., Kretschmer, D., Bach, T.-H. L., Queck, S. Y., Li, M., Kennedy, A. D., Dorward, D. W., Klebanoff, S. J., Peschel, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1656 · Cited by 1,046
Self-citationInnate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 942
Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C. N., & Murphy, P. M. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001578 · Cited by 764
Self-citationFormyl-peptide receptors revisited
LE, Y., MURPHY, P., & WANG, J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02316-5 · Cited by 597
Queck, S. Y., Jameson-Lee, M., Villaruz, A. E., Bach, T.-H. L., Khan, B. A., Sturdevant, D. E., Ricklefs, S. M., Li, M., & Otto, M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.005 · Cited by 595
Self-citationToll-like receptors — taking an evolutionary approach
Leulier, F., & Lemaitre, B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2303 · Cited by 581
Poring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia
Bubeck Wardenburg, J., Bae, T., Otto, M., DeLeo, F. R., & Schneewind, O. (2007) · Nature Medicine · doi:10.1038/nm1207-1405 · Cited by 492
Self-citationChemotaxis Inhibitory Protein of Staphylococcus aureus, a Bacterial Antiinflammatory Agent
de Haas, C. J. C., Veldkamp, K. E., Peschel, A., Weerkamp, F., Van Wamel, W. J. B., Heezius, E. C. J. M., Poppelier, M. J. J. G., Van Kessel, K. P. M., & van Strijp, J. A. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031636 · Cited by 471
Self-citationMIGEOTTE, I., COMMUNI, D., & PARMENTIER, M. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.009 · Cited by 457
Perretti, M., Chiang, N., La, M., Fierro, I. M., Marullo, S., Getting, S. J., Solito, E., & Serhan, C. N. (2002) · Nature Medicine · doi:10.1038/nm786 · Cited by 447
Toll-like receptors and innate immunity
Uematsu, S., & Akira, S. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0084-y · Cited by 441
Su, S. B., Gong, W., Gao, J.-L., Shen, W., Murphy, P. M., Oppenheim, J. J., & Wang, J. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.395 · Cited by 429
The role of virulence determinants in community-associated MRSA pathogenesis
Diep, B. A., & Otto, M. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.05.002 · Cited by 328
Self-citationThe Staphylococcus aureus “superbug”
Foster, T. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci23825 · Cited by 272
The Staphylococcus aureus “superbug”
Foster, T. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423825 · Cited by 262
Mobile Genetic Element-Encoded Cytolysin Connects Virulence to Methicillin Resistance in MRSA
Queck, S. Y., Khan, B. A., Wang, R., Bach, T.-H. L., Kretschmer, D., Chen, L., Kreiswirth, B. N., Peschel, A., DeLeo, F. R., & Otto, M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000533 · Cited by 226
Self-citationMurphy, P. M., Ozçelik, T., Kenney, R. T., Tiffany, H. L., McDermott, D., & Francke, U. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42563-x · Cited by 203
Christophe, T., Karlsson, A., Dugave, C., Rabiet, M.-J., Boulay, F., & Dahlgren, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007769200 · Cited by 202
Self-citationCommunity-Acquired Methicillin-Resistant Staphylococcus aureus: An Emerging Pathogen
Saïd-Salim, B., Mathema, B., & Kreiswirth, B. N. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502231 · Cited by 198
Diep, B. A., Palazzolo-Ballance, A. M., Tattevin, P., Basuino, L., Braughton, K. R., Whitney, A. R., Chen, L., Kreiswirth, B. N., Otto, M., DeLeo, F. R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003198 · Cited by 188
Self-citationLigand recognition and activation of formyl peptide receptors in neutrophils
Fu, H., Karlsson, J., Bylund, J., Movitz, C., Karlsson, A., & Dahlgren, C. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0905498 · Cited by 159
Palazzolo-Ballance, A. M., Reniere, M. L., Braughton, K. R., Sturdevant, D. E., Otto, M., Kreiswirth, B. N., Skaar, E. P., & DeLeo, F. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.500 · Cited by 142
Self-citationA New Staphylococcal Anti-Inflammatory Protein That Antagonizes the Formyl Peptide Receptor-Like 1
Prat, C., Bestebroer, J., de Haas, C. J. C., van Strijp, J. A. G., & van Kessel, K. P. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8017 · Cited by 137
Differential Expansion of the N-Formylpeptide Receptor Gene Cluster in Human and Mouse
Gao, J., Chen, H., Filie, J. D., Kozak, C. A., & Murphy, P. M. (1998) · Genomics · doi:10.1006/geno.1998.5376 · Cited by 136
Prevalence of agr Dysfunction among Colonizing Staphylococcus aureus Strains
Shopsin, B., Drlica‐Wagner, A., Mathema, B., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/592051 · Cited by 132
Identification and characterization of an endogenous chemotactic ligand specific for FPRL2
Migeotte, I., Riboldi, E., Franssen, J., Grégoire, F., Loison, C., Wittamer, V., Detheux, M., Robberecht, P., Costagliola, S., Vassart, G., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041277 · Cited by 123
Dahlgren, C., Christophe, T., Boulay, F., Madianos, P., Rabiet, M., & Karlsson, A. (2000) · Blood · doi:10.1182/blood.v95.5.1810.005k06_1810_1818 · Cited by 121
Self-citationSomerville, G. A., Cockayne, A., Dürr, M. C., Peschel, A., Otto, M. J., & Musser, J. M. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.22.6686-6694.2003 · Cited by 121
Self-citationSouthgate, E. L., He, R. L., Gao, J., Murphy, P. M., Nanamori, M., & Ye, R. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1429 · Cited by 117
Hartt, J. K., Barish, G. D., Murphy, P. M., & Gao, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.741 · Cited by 104
Haas, P., de Haas, C. J. C., Kleibeuker, W., Poppelier, M. J. J. G., van Kessel, K. P. M., Kruijtzer, J. A. W., Liskamp, R. M. J., & van Strijp, J. A. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5704 · Cited by 93
Devosse, T., Guillabert, A., D’Haene, N., Berton, A., de Nadaï, P., Noel, S., Brait, M., Franssen, J., Sozzani, S., Salmon, I. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803128 · Cited by 80
Cui, Y., Le, Y., Yazawa, H., Gong, W., & Wang, J. M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.4.628 · Cited by 79
Hecht, I., Rong, J., Sampaio, A. L. F., Hermesh, C., Rutledge, C., Shemesh, R., Toporik, A., Beiman, M., Dassa, L., Niv, H., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145821 · Cited by 58
Dürr, M. C., Kristian, S. A., Otto, M. J., Matteoli, G., Margolis, P. S., Trias, J., van Kessel, K. P. M., van Strijp, J. A. G., Bohn, E., Landmann, R. M., et al. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00610.x · Cited by 53
Self-citationA truncated form of CK β 8‐1 is a potent agonist for human formyl peptide‐receptor‐like 1 receptor
Elagöz, A., Henderson, D. J., Babu, P. S., Salter, S., Grahames, C., Bowers, L., Roy, M., LaPlante, P., Grazzini, E., Ahmad, S., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705592 · Cited by 47
Önnheim, K., Bylund, J., Boulay, F., Dahlgren, C., & Forsman, H. F. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02873.x · Cited by 40
Self-citationMolecular evolution of the N-formyl peptide and C5a receptors in non-human primates
Álvarez, V., Coto, E., González-Roces, S., López-Larrea, C., Setién, F., & López-Larrea, C. (1996) · Immunogenetics · doi:10.1007/bf02602806 · Cited by 33
Karlsson, J., Fu, H., Boulay, F., Bylund, J., & Dahlgren, C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.010 · Cited by 31
Self-citationKahl, B. C., & Peters, G. (2007) · Science · doi:10.1126/science.1139628 · Cited by 26
Mader, D., Rabiet, M., Boulay, F., & Peschel, A. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.01.014 · Cited by 22
Self-citationEffect of bacterial products on neutrophil chemotaxis
Kalmar, J. R., & Dyke, T. E. V. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)36009-x · Cited by 14
Cited by
Pathogenicity and virulence of Staphylococcus aureus
Cheung, G. Y. C., Bae, J. S., & Otto, M. (2021) · Virulence · doi:10.1080/21505594.2021.1878688 · Cited by 1,380
Self-citationOtto, M. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.11.004 · Cited by 643
Self-citationOtto, M. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-042711-140023 · Cited by 606
Self-citationStaphylococcal manipulation of host immune responses
Thammavongsa, V., Kim, H. K., Missiakas, D., & Schneewind, O. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3521 · Cited by 598
Staphylococcus δ-toxin induces allergic skin disease by activating mast cells
Nakamura, Y., Oscherwitz, J., Cease, K. B., Chan, S. M., Muñoz-Planillo, R., Hasegawa, M., Villaruz, A. E., Cheung, G. Y. C., McGavin, M. J., Travers, J. B., et al. (2013) · Nature · doi:10.1038/nature12655 · Cited by 558
Self-citation
Metadata
- Authors
- Kretschmer, D., Gleske, A.-K., Rautenberg, M., Wang, R., Köberle, M., Bohn, E., Schöneberg, T., Rabiet, M.-J., Boulay, F., Klebanoff, S. J., van Kessel, K. A., van Strijp, J. A., Otto, M., & Peschel, A.
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 7
- Issue
- 6
- Pages
- 463-473
- ISSN
- 1931-3128 (ISSN-L)
- OpenAlex
- W2013424910
- Cited by
- 282
- References
- 44
- FWCI
- 8.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.